➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Colorcon
Dow
Mallinckrodt
Boehringer Ingelheim

Last Updated: May 27, 2020

DrugPatentWatch Database Preview

Litigation Details for Carrier Corporation v. Goodman Global Inc. (D. Del. 2012)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Carrier Corporation v. Goodman Global Inc. (D. Del. 2012)

Docket   Start Trial Date Filed 2012-07-19
Court District Court, D. Delaware Date Terminated 2017-03-16
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand Plaintiff Referred To
Parties CARRIER CORPORATION; GOODMAN DISTRIBUTION INC.; GOODMAN GLOBAL HOLDINGS INC.; GOODMAN GLOBAL INC.; GOODMAN MANUFACTURING COMPANY L.P.; GOODMAN SALES COMPANY
Patents 10,114,012; 10,232,004; 10,252,010; 5,294,005; 7,012,066; 7,034,007; 7,126,019
Attorneys Abigail E. Lauer; Ali Dhanani; Anders P. Fjellstedt; Anne Shea Gaza; Elizabeth Durham Flannery; Frederick L. Cottrell , III; Gregg F. LoCascio; Jack B. Blumenfeld; Jason James Rawnsley; Joseph F. Edell; Katharine M. Burke; Kelli J. Powell; Kevin S. Prussia; Lisa M. Thomas; Maryellen Noreika; Michelle J. Eber; Paul R. Morico; Robinson Vu; Scott F. Partridge; Sean M. McEldowney; William F. Lee
Firms Morris, Nichols, Arsht & Tunnell; Richards, Layton & Finger, PA; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Carrier Corporation v. Goodman Global Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in Carrier Corporation v. Goodman Global Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Carrier Corporation v. Goodman Global Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2014-08-18 319 Exhibit 1-15 16 RE, PM, LE, VG 114 10 114 12 AF, RE, PM, LE 114 23 … THE ‘004 PATENT 1. United States Patent No. 7,243,004 (the ‘004 patent), titled “Self-Configuring…States any patented invention during the term of the patent therefor, infringes the patent.” 35 U.S.…pre-suit knowledge of the ‘004 patent or the fact that Carrier had a patent on auto-configuration for an… ‘004 patent. 31. Whether others have copied the invention claimed in the ‘004 patent, supporting External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
AstraZeneca
Medtronic
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.